News

The phase II clinical trial is expected to enroll 90 adults with genotype 1 hepatitis C virus (HCV) who have failed previous therapy with the current standard of

Isotretinoin, marketed by Roche as Accutane, is approved to treat severe recalcitrant nodular acne. The drug is highly effective in the treatment of this form of acne, but

The state-of-the-art laboratory will allow Tepnel to consolidate its existing pharmaceutical services business into a single location, with its primary function being the analysis of therapeutic proteins, including

The contracts are worth GBP33 million and will help prepare for and reduce the impact of a possible flu pandemic. The vaccine will be used to carry out

Erbitux is currently licensed in the European Union for metastatic colorectal cancer after being first approved in Switzerland in December 2003. Germany’s Merck licensed the right to market

The French drug maker revealed its forecast for Acomplia upon posting fourth quarter financial results. Originally slated for a second quarter release, the drug is now more likely

Patient enrollment in the so-called Genasis trial was expected to be complete by the end of March. However, the company has been slow to reach its target number

NX-1207 has completed two earlier phase I and II trials where the drug produced on average over 23% prostate shrinkage in one month with minimal side effects. Overall

ZIO-201 is the active metabolite of ifosfamide, a frequently used, yet highly toxic, treatment for sarcoma. ZIO-201 is designed to deliver therapeutic activity at higher doses with less